Telefonaktiebolaget LM Ericsson Class B (0O87)
London Exchange · UK · prices in SEK · close of 20 Oct 2026
Key indicators
| Last close | SEK 104.38 |
|---|---|
| 52-week range | 82.08 – 126.38 |
| Return, 1 month / 3 months | +5.7% / +14.6% |
| Return, 1 year / 3 years | +36.7% / +120.7% |
| Trend | Uptrend |
| RSI (14) | 67 |
| Volatility (1 year) | 33.7% |
| Worst drawdown (1 year) | -27.9% |
| Average daily value traded | 539.39M SEK |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ericsson is a Swedish supplier of telecommunications equipment and related software and services, based in Stockholm. The company builds radio access network gear, mobile core network systems and transport equipment used by mobile network operators to run their networks. It also provides managed services, network rollout support and software that helps operators manage capacity and coverage. Its customers are mainly telecom operators and service providers around the world, along with enterprises that run private cellular networks.
The shares are listed on the London Exchange in UK under the code 0O87, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Telefonaktiebolaget LM Ericsson Class B (0O87) trades on the London Exchange in UK. It last closed at SEK 104.38 on 20 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 1,131 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 36.7% and over the last three months it rose 14.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 3.7% | ||
| From 52-week high | -16.5% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 14.6% | ||
| 6-month return | 0.3% | ||
| 12-month return, skipping the last month | 29.3% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.9% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 539.39M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | +9.9% |
|---|---|
| 1 month | +5.7% |
| 3 months | +14.6% |
| 6 months | +0.3% |
| 1 year | +36.7% |
| 3 years | +120.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 96.03 / 100.67 |
|---|---|
| Golden / death cross (60 days) | Death, 39 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.36 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Sep 2026 | SEK 1.5000 |
| 1 Apr 2026 | SEK 1.5000 |
| 26 Sep 2025 | SEK 1.4200 |
| 26 Mar 2025 | SEK 1.4300 |
| 1 Oct 2024 | SEK 1.3500 |
| 4 Apr 2024 | SEK 1.3500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.